Stoke Therapeutics Inc (STOK)

12:38 PM

Decoding Stoke Therapeutics Inc (STOK): A Strategic SWOT Insight - GuruFocus

12:38 PM

12:10 PM

Stoke Therapeutics Advances in RNA Medicine and Financial Growth - TipRanks

12:10 PM

12:05 PM

Stoke Therapeutics Inc (STOK) Q3 2025 Earnings Call Highlights: Strong Financial Position and ... - Yahoo Finance

12:05 PM

Nov 04, 2025

Stoke Therapeutics earnings missed by $0.07, revenue topped estimates - Investing.com Canada

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics' Revenue Beats Expectations But Losses Widen - Finimize

Nov 04, 2025

Nov 04, 2025

Earnings call transcript: Stoke Therapeutics Q3 2025 shows revenue beat - Investing.com

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics Inc (STOK) Q3 2025 Earnings: Revenue Surges t - GuruFocus

Nov 04, 2025

Nov 04, 2025

Earnings Flash (STOK) Stoke Therapeutics, Inc. Reports Q3 Revenue $10.6M, vs. FactSet Est of $6.2M - MarketScreener

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics : Q3 2025 Webcast Slides - MarketScreener

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics Q3 revenue beats estimates on Acadia, Biogen agreements - TradingView

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Nov 04, 2025

Nov 04, 2025

Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - FinancialContent

Nov 04, 2025

Nov 04, 2025

JPMorgan Chase & Co. Raises Stoke Therapeutics (NASDAQ:STOK) Price Target to $25.00 - MarketBeat

Nov 04, 2025

Nov 04, 2025

What technical models suggest about Stoke Therapeutics Inc.’s comebackJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com

Nov 04, 2025

Nov 04, 2025

Can Stoke Therapeutics Inc. stock resist sector downturnsMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com

Nov 04, 2025

Nov 04, 2025

Using portfolio simulators with Stoke Therapeutics Inc. includedJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com

Nov 04, 2025

Nov 04, 2025

Live market analysis of Stoke Therapeutics Inc.2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com

Nov 04, 2025

Nov 03, 2025

JP Morgan Maintains Stoke Therapeutics (STOK) Neutral Recommendation - Nasdaq

Nov 03, 2025

Nov 03, 2025

Stoke Therapeutics (STOK): JP Morgan Raises Price Target, Mainta - GuruFocus

Nov 03, 2025

Nov 03, 2025

Why Stoke Therapeutics Inc. stock attracts high net worth investorsQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Stoke Therapeutics Inc. stock sustain institutional interestMarket Activity Summary & Daily Momentum Trading Reports - newser.com

Nov 03, 2025

Nov 03, 2025

What insider trading reveals about Stoke Therapeutics Inc. stockGold Moves & High Accuracy Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Stoke Therapeutics Inc. stock a good choice for value investorsQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Does Stoke Therapeutics Inc. show high probability of reboundWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Will Stoke Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com

Nov 03, 2025

Nov 02, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 02, 2025

Nov 01, 2025

Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS

Nov 01, 2025

Nov 01, 2025

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat

Nov 01, 2025

Oct 31, 2025

Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com

Oct 31, 2025

Oct 30, 2025

Stoke Therapeutics, Inc. (STOK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025

Oct 30, 2025

Total debt per share of Stoke Therapeutics, Inc. – BER:0GT - TradingView

Oct 30, 2025

Oct 30, 2025

Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates - Yahoo Finance

Oct 30, 2025

Oct 29, 2025

Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - Nasdaq

Oct 29, 2025